- Home
- SIF vs BIVI Comparison
SIF vs BIVI Comparison
Compare SIF & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- BIVI
- Stock Information
- Founded
- SIF 1913
- BIVI 2013
- Country
- SIF United States
- BIVI United States
- Employees
- SIF N/A
- BIVI N/A
- Industry
- SIF Office Equipment/Supplies/Services
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- BIVI Health Care
- Exchange
- SIF Nasdaq
- BIVI Nasdaq
- Market Cap
- SIF 17.5M
- BIVI 18.8M
- IPO Year
- SIF N/A
- BIVI N/A
- Fundamental
- Price
- SIF $2.70
- BIVI $0.80
- Analyst Decision
- SIF
- BIVI Strong Buy
- Analyst Count
- SIF 0
- BIVI 1
- Target Price
- SIF N/A
- BIVI $30.00
- AVG Volume (30 Days)
- SIF 4.2K
- BIVI 235.0K
- Earning Date
- SIF 05-08-2025
- BIVI 05-13-2025
- Dividend Yield
- SIF N/A
- BIVI N/A
- EPS Growth
- SIF N/A
- BIVI N/A
- EPS
- SIF N/A
- BIVI N/A
- Revenue
- SIF $85,042,000.00
- BIVI N/A
- Revenue This Year
- SIF N/A
- BIVI N/A
- Revenue Next Year
- SIF N/A
- BIVI N/A
- P/E Ratio
- SIF N/A
- BIVI N/A
- Revenue Growth
- SIF 41.17
- BIVI N/A
- 52 Week Low
- SIF $2.73
- BIVI $0.80
- 52 Week High
- SIF $5.96
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- SIF 36.51
- BIVI 31.30
- Support Level
- SIF $2.65
- BIVI $0.80
- Resistance Level
- SIF $2.88
- BIVI $1.00
- Average True Range (ATR)
- SIF 0.09
- BIVI 0.10
- MACD
- SIF 0.02
- BIVI -0.00
- Stochastic Oscillator
- SIF 48.39
- BIVI 0.00
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.